These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12916356)

  • 1. [The use of oxymetazoline in nasal endoscopic sinus surgery].
    Zhen H; Gao Q; Cui Y; Hua X; Li H; Feng J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):281-2. PubMed ID: 12916356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The observation of the ciliotoxicity of nasal mucosa with nasal decongestant].
    Teng Y; Zhang X; Xu G; Cai Q; Xu J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):824-6. PubMed ID: 16375111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of nasal blood flow and airflow in the decongestant response to oxymetazoline.
    Vaidyanathan S; Williamson P; Lipworth B
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):77-80. PubMed ID: 22289724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new oxymetazoline preparation in the treatment of nasal congestion. A multicentre trial.
    Practitioner; 1975 May; 214(1283):685-688. PubMed ID: 49890
    [No Abstract]   [Full Text] [Related]  

  • 6. A topical nasal decongestant for children.
    Neffson AH
    Eye Ear Nose Throat Mon; 1968 Mar; 47(3):121-3. PubMed ID: 4171734
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
    Druce HM; Ramsey DL; Karnati S; Carr AN
    Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oxymetazoline nose drops on acute sinusitis in the rabbit.
    Bende M; Fukami M; Arfors KE; Mark J; Stierna P; Intaglietta M
    Ann Otol Rhinol Laryngol; 1996 Mar; 105(3):222-5. PubMed ID: 8615587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oxymetazoline nasal spray on the nasal cycle assessed by long-term rhinoflowmetry.
    Braun T; Rich M; Berghaus A; Kramer MF
    Rhinology; 2012 Dec; 50(4):370-5. PubMed ID: 23181250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa.
    Browning S; Housley D; Richards R; Eccles R
    Acta Otolaryngol; 1997 Nov; 117(6):851-5. PubMed ID: 9442826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of micronized cellulose powder on the efficacy of topical oxymetazoline in allergic rhinitis.
    Valerieva A; Popov TA; Staevska M; Kralimarkova T; Petkova E; Valerieva E; Mustakov T; Lazarova T; Dimitrov V; Church MK
    Allergy Asthma Proc; 2015; 36(6):e134-9. PubMed ID: 26133030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
    Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
    Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A topical nasal decongestant for children.
    Weimann ML
    J Med Soc N J; 1967 Jun; 64(6):260-1. PubMed ID: 4167128
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular effects of topical oxymetazoline on human nasal mucosa.
    Bende M; Löth S
    J Laryngol Otol; 1986 Mar; 100(3):285-8. PubMed ID: 3950497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Which nasal spray is preferred by patients?].
    Månsson I; Fredriksson H
    Lakartidningen; 1991 Feb; 88(6):406. PubMed ID: 1705641
    [No Abstract]   [Full Text] [Related]  

  • 17. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits.
    Suh SH; Chon KM; Min YG; Jeong CH; Hong SH
    Acta Otolaryngol; 1995 Sep; 115(5):664-71. PubMed ID: 8928640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxymetazoline Applied Topically to the Nasal Mucosa Decreases Trans-Mucosal Nitrous Oxide Exchange for the Middle Ear.
    Teixeira MS; Alper CM; Martin BS; Helal N; Doyle BM; Doyle WJ
    Ann Otol Rhinol Laryngol; 2016 May; 125(5):400-7. PubMed ID: 26611245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.